|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamazaki S, Yamakawa A, Ito Y, Ohtani M,
Higashi H, Hatakeyama M and Azuma T: The CagA protein of
Helicobacter pylori is translocated into epithelial cells and binds
to SHP-2 in human gastric mucosa. J Infect Dis. 187:334–337. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang J, Zhang F and Niu R: Functions of
Shp2 in cancer. J Cell Mol Med. 19:2075–2083. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Inoue K: Gastric cancer risk
classification (ABC classification). Nihon Rinsho. 71:1472–1478.
2013.(In Japanese). PubMed/NCBI
|
|
6
|
Hatakeyama M: H. pylori oncoprotein CagA
and gastric cancer. Nihon Rinsho. 70:1699–1704. 2012.(In Japanese).
PubMed/NCBI
|
|
7
|
Hatakeyama M: Deregulation of SHP-2
tyrosine phosphatase by the Helicobacter pylori virulence factor
CagA. Keio J Med. 51 (Suppl 2):S26–S32. 2002. View Article : Google Scholar
|
|
8
|
Uemura N, Okamoto S, Yamamoto S, Matsumura
N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ:
Helicobacter pylori infection and the development of gastric
cancer. N Engl J Med. 345:784–789. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Müller PJ, Rigbolt KT, Paterok D, Piehler
J, Vanselow J, Lasonder E, Andersen JS, Schaper F and Sobota RM:
Protein tyrosine phosphatase SHP2/PTPN11 mistargeting as a
consequence of SH2-domain point mutations associated with Noonan
Syndrome and leukemia. J Proteomics. 84:132–147. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mutesa L, Pierquin G, Janin N, Segers K,
Thomée C, Provenzi M and Bours V: Germline PTPN11 missense mutation
in a case of Noonan syndrome associated with mediastinal and
retroperitoneal neuroblastic tumors. Cancer Genet Cytogenet.
182:40–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee KA, Williams B, Roza K, Ferguson H,
David K, Eddleman K, Stone J, Edelmann L, Richard G, Gelb BD and
Kornreich R: PTPN11 analysis for the prenatal diagnosis of Noonan
syndrome in fetuses with abnormal ultrasound findings. Clin Genet.
75:190–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Motegi S, Yokoyama Y, Ogino S, Yamada K,
Uchiyama A, Perera B, Takeuchi Y, Ohnishi H and Ishikawa O:
Pathogenesis of multiple lentigines in LEOPARD syndrome with PTPN11
gene mutation. Acta Derm Venereol. 95:978–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tartaglia M, Niemeyer CM, Shannon KM and
Loh ML: SHP-2 and myeloid malignancies. Curr Opin Hematol.
11:44–50. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ibáñez M, Carbonell-Caballero J,
García-Alonso L, Such E, Jiménez-Almazán J, Vidal E, Barragán E,
López-Pavía M, LLop M, Martín I, et al: The mutational landscape of
acute promyelocytic leukemia reveals an interacting network of
co-occurrences and recurrent mutations. PLoS One. 11:e01483462016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen L, Chen W, Mysliwski M, Serio J, Ropa
J, Abulwerdi FA, Chan RJ, Patel JP, Tallman MS, Paietta E, et al:
Mutated Ptpn11 alters leukemic stem cell frequency and reduces the
sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.
Leukemia. 29:1290–1300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan L, Lu L, Yang Y, Sun H, Chen X, Huang
Y, Wang X, Zou L and Bao L: Genetic mutational profiling analysis
of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a
prognostic indicator for inferior survival. Ann Hematol.
94:1817–1828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang WY, Chen XJ, Wang SC, Guo Y, Liu TF,
Chang LX, Liu F and Zhu XF: Gene mutations and clinical
characteristics in children with juvenile myelomonocytic leukemia.
Zhongguo Dang Dai Er Ke Za Zhi. 17:1–5. 2015.(In Chinese).
PubMed/NCBI
|
|
18
|
Pugh TJ, Morozova O, Attiyeh EF,
Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M,
Kiezun A, et al: The genetic landscape of high-risk neuroblastoma.
Nat Genet. 45:279–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Obasaju P, Brondon J, Mir S, Fordham LA,
Lee S and Blatt J: Somatic PTPN11 mutation in a child with
neuroblastoma and protein losing enteropathy. J Pediatr Hematol
Oncol. 40:328–330. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McFarlane J, Knight T, Sinha A, Cole T,
Kiely N and Freeman R: Exostoses, enchondromatosis and
metachondromatosis; diagnosis and management. Acta Orthop Belg.
82:102–105. 2016.PubMed/NCBI
|
|
21
|
Bowen ME, Boyden ED, Holm IA,
Campos-Xavier B, Bonafé L, Superti-Furga A, Ikegawa S,
Cormier-Daire V, Bovée JV, Pansuriya TC, et al: Loss-of-function
mutations in PTPN11 cause metachondromatosis, but not Ollier
disease or Maffucci syndrome. PLoS Genet. 7:e10020502011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Siegfried A, Cances C, Denuelle M, Loukh
N, Tauber M, Cavé H and Delisle MB: Noonan syndrome, PTPN11
mutations, and brain tumors. A clinical report and review of the
literature. Am J Med Genet A. 173:1061–1065. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rankin J, Short J, Turnpenny P, Castle B
and Hanemann CO: Medulloblastoma in a patient with the PTPN11
p.Thr468Met mutation. Am J Med Genet A. 161A:2027–2029. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roccograndi L, Binder ZA, Zhang L, Aceto
N, Zhang Z, Bentires-Alj M, Nakano I, Dahmane N and O'Rourke DM:
SHP2 regulates proliferation and tumorigenicity of glioma stem
cells. J Neurooncol. 135:487–496. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thiel C, Wilken M, Zenker M, Sticht H,
Fahsold R, Gusek-Schneider GC and Rauch A: Independent NF1 and
PTPN11 mutations in a family with neurofibromatosis-Noonan
syndrome. Am J Med Genet A. 149A:1263–1267. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nair S, Fort JA, Yachnis AT and Williams
CA: Optic nerve pilomyxoid astrocytoma in a patient with Noonan
syndrome. Pediatr Blood Cancer. 62:1084–1086. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu Z, Wang X, Fang H, Liu Y, Chen D, Zhang
Q, Liu X, Wei D, Qu C and Wang S: A tyrosine phosphatase SHP2
gain-of-function mutation enhances malignancy of breast carcinoma.
Oncotarget. 7:5664–5676. 2016.PubMed/NCBI
|
|
28
|
Beigbeder A, Chartier FJM and Bisson N:
MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11
phosphatase in HER2-positive breast cancer cells. Sci Rep.
7:115142017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Q, Li Y, Zhao R, Wang X, Fan C, Xu
Y, Liu Y, Li J and Wang S: The gain-of-function mutation E76K in
SHP2 promotes CAC tumorigenesis and induces EMT via the
Wnt/β-catenin signaling pathway. Mol Carcinog. 57:619–628. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gagné-Sansfaçon J, Coulombe G, Langlois
MJ, Langlois A, Paquet M, Carrier J, Feng GS, Qu CK and Rivard N:
SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis
but prevents colitis-associated cancer development. Oncotarget.
7:65676–65695. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang N, Liu H, Yue G, Zhang Y, You J and
Wang H: Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion
Torrent Sequencing. PLoS One. 11:e01535462016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Je EM, Choi YJ, Yoo NJ and Lee SH:
Oncogenic PTPN11 mutations are rare in solid tumors. Pathol Oncol
Res. 21:225–227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martinelli S, Carta C, Flex E, Binni F,
Cordisco EL, Moretti S, Puxeddu E, Tonacchera M, Pinchera A,
McDowell HP, et al: Activating PTPN11 mutations play a minor role
in pediatric and adult solid tumors. Cancer Genet Cytogenet.
166:124–129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhuo C, Shao M, Chen C, Lin C, Jiang D,
Chen G, Tian H, Wang L, Li J and Lin X: Chemotherapy effectiveness
and prognosis of gastric cancer influenced by PTPN11 polymorphisms.
Cell Physiol Biochem. 39:1537–1552. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He C, Tu H, Sun L, Xu Q, Li P, Gong Y,
Dong N and Yuan Y: Helicobacter pylori-related host gene
polymorphisms associated with susceptibility of gastric
carcinogenesis: A two-stage case-control study in Chinese.
Carcinogenesis. 34:1450–1457. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu F, Loh M, Hill J, Lee S, Koh KX, Lai
KW, Salto-Tellez M, Iacopetta B, Yeoh KG and Soong R; Singapore
Gastric Cancer Consortium, : Genetic factors associated with
intestinal metaplasia in a high risk Singapore-Chinese population:
A cohort study. BMC Gastroenterol. 9:762009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang J, Jia ZF, Kong F, Jin MS, Wang YP,
Tian S, Suo J and Cao X: Association of polymorphism of PTPN 11
encoding SHP-2 with gastric atrophy but not gastric cancer in
Helicobacter pylori seropositive Chinese population. BMC
Gastroenterol. 12:892012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hishida A, Matsuo K, Goto Y, Naito M,
Wakai K, Tajima K and Hamajima N: Associations of a PTPN11 G/A
polymorphism at intron 3 with Helicobactor pylori seropositivity,
gastric atrophy and gastric cancer in Japanese. BMC Gastroenterol.
9:512009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sapari NS, Loh M, Vaithilingam A and Soong
R: Clinical potential of DNA methylation in gastric cancer: A
meta-analysis. PLoS One. 7:e362752012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li J, Chen C, Bi X, Zhou C, Huang T, Ni C,
Yang P, Chen S, Ye M and Duan S: DNA methylation of CMTM3, SSTR2,
and MDFI genes in colorectal cancer. Gene. 630:1–7. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kristensen LS, Mikeska T, Krypuy M and
Dobrovic A: Sensitive Melting Analysis after Real Time-Methylation
Specific PCR (SMART-MSP): High-throughput and probe-free
quantitative DNA methylation detection. Nucleic Acids Res.
36:e422008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Testino G, Testino R and Ancarani AO:
Helicobacter pylori and gastric carcinogenesis. Recenti Prog Med.
92:573–577. 2001.(In Italian). PubMed/NCBI
|
|
43
|
Jiang J, Jin MS, Kong F, Wang YP, Jia ZF,
Cao DH, Ma HX, Suo J and Cao XY: Increased expression of tyrosine
phosphatase SHP-2 in Helicobacter pylori-infected gastric cancer.
World J Gastroenterol. 19:575–580. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fukushige S and Horii A: DNA methylation
in cancer: A gene silencing mechanism and the clinical potential of
its biomarkers. Tohoku J Exp Med. 229:173–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li S, Hsu DD, Wang H and Feng GS: Dual
faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in
tumorigenesis. Front Med. 6:275–279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bard-Chapeau EA, Li S, Ding J, Zhang SS,
Zhu HH, Princen F, Fang DD, Han T, Bailly-Maitre B, Poli V, et al:
Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular
carcinogenesis. Cancer Cell. 19:629–639. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jiang C, Hu F, Tai Y, Du J, Mao B, Yuan Z,
Wang Y and Wei L: The tumor suppressor role of Src homology
phosphotyrosine phosphatase 2 in hepatocellular carcinoma. J Cancer
Res Clin Oncol. 138:637–646. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xu R, Yu Y, Zheng S, Zhao X, Dong Q, He Z,
Liang Y, Lu Q, Fang Y, Gan X, et al: Overexpression of Shp2
tyrosine phosphatase is implicated in leukemogenesis in adult human
leukemia. Blood. 106:3142–3149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lucci MA, Orlandi R, Triulzi T, Tagliabue
E, Balsari A and Villa-Moruzzi E: Expression profile of tyrosine
phosphatases in HER2 breast cancer cells and tumors. Cell Oncol.
32:361–372. 2010.PubMed/NCBI
|
|
50
|
Hu ZQ, Ma R, Zhang CM, Li J, Li L, Hu ZT,
Gao QI and Li WM: Expression and clinical significance of tyrosine
phosphatase SHP2 in thyroid carcinoma. Oncol Lett. 10:1507–1512.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cai P, Guo W, Yuan H, Li Q, Wang W, Sun Y,
Li X and Gu Y: Expression and clinical significance of tyrosine
phosphatase SHP-2 in colon cancer. Biomed Pharmacother. 68:285–290.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Luo X, Liao R, Hanley KL, Zhu HH, Malo KN,
Hernandez C, Wei X, Varki NM, Alderson N, Chu C, et al: Dual Shp2
and Pten deficiencies promote non-alcoholic steatohepatitis and
genesis of liver tumor-initiating cells. Cell Rep. 17:2979–2993.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dong S, Li FQ, Zhang Q, Lv KZ, Yang HL,
Gao Y and Yu JR: Expression and clinical significance of SHP2 in
gastric cancer. J Int Med Res. 40:2083–2089. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kim JS, Shin OR, Kim HK, Cho YS, An CH,
Lim KW and Kim SS: Overexpression of protein phosphatase
non-receptor type 11 (PTPN11) in gastric carcinomas. Dig Dis Sci.
55:1565–1569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tramacere I, Negri E, Pelucchi C, Bagnardi
V, Rota M, Scotti L, Islami F, Corrao G, La Vecchia C and Boffetta
P: A meta-analysis on alcohol drinking and gastric cancer risk. Ann
Oncol. 23:28–36. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang D, Li C, Xu Y, Xing Y, Qu L, Guo Y,
Zhang Y, Sun X and Suo J: Clinicopathological characteristics and
prognosis of alpha-fetoprotein positive gastric cancer in Chinese
patients. Int J Clin Exp Pathol. 8:6345–6355. 2015.PubMed/NCBI
|
|
57
|
Han T, Xiang DM, Sun W, Liu N, Sun HL, Wen
W, Shen WF, Wang RY, Chen C, Wang X, et al: PTPN11/Shp2
overexpression enhances liver cancer progression and predicts poor
prognosis of patients. J Hepatol. 63:651–660. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chang W, Gao X, Han Y, Du Y, Liu Q, Wang
L, Tan X, Zhang Q, Liu Y, Zhu Y, et al: Gene expression
profiling-derived immunohistochemistry signature with high
prognostic value in colorectal carcinoma. Gut. 63:1457–1467. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen SJ, Liu H, Liao CT, Huang PJ, Huang
Y, Hsu A, Tang P, Chang YS, Chen HC and Yen TC: Ultra-deep targeted
sequencing of advanced oral squamous cell carcinoma identifies a
mutation-based prognostic gene signature. Oncotarget.
6:18066–18080. 2015.PubMed/NCBI
|
